Which is a better indicator of renal function in athletes, creatinine or cystatin C (Cysteine Proteinase Inhibitor C)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cystatin C is a Better Indicator of Renal Function in Athletes Than Creatinine

Cystatin C is superior to creatinine for assessing renal function in athletes due to its independence from muscle mass, providing more accurate glomerular filtration rate estimation in this population.

Why Creatinine is Problematic in Athletes

Creatinine-based measurements have significant limitations when assessing renal function in athletes:

  • Creatinine is produced from muscle catabolism, making it highly dependent on muscle mass 1
  • Athletes typically have higher muscle mass, which can lead to elevated serum creatinine levels not reflective of actual kidney function
  • This can result in underestimation of renal impairment when using creatinine-based equations 2
  • In a study of recreational male runners, creatinine increased by 41% after marathon running compared to only 21% for cystatin C, suggesting creatinine is more affected by muscle damage during exercise 2

Advantages of Cystatin C in Athletes

Cystatin C offers several benefits for assessing renal function in athletic populations:

  • Produced at a constant rate by all nucleated cells in the body 1
  • Not influenced by muscle mass, gender, or age 1, 3
  • Less affected by extreme exercise and muscle damage 2
  • Provides more reliable GFR estimation in individuals with altered muscle mass 4
  • Shows less variance compared to creatinine at different BMI levels in athletes 3

A 2024 study examining men with testosterone-induced muscle hypertrophy (all characterized as competitive or recreational athletes) found that cystatin C measurements displayed less variance compared to creatinine across different BMI categories 3.

Clinical Applications and Recommendations

When assessing renal function in athletes:

  1. Use cystatin C-based equations (eGFRcys) as the primary method for GFR estimation 1, 4
  2. Consider combined creatinine-cystatin C equations (eGFRcr-cys) for even greater accuracy in some cases 1
  3. Recognize that all creatinine-based equations may overestimate GFR in individuals with high muscle mass 4, 5
  4. Be aware that renal impairment is common during and after severe exercise, making accurate assessment crucial 2

Important Considerations

  • The KDIGO guidelines recommend using the most accurate, validated equations to estimate GFR, preferably with a combination of serum creatinine and cystatin C 1
  • For athletes specifically, cystatin C-based equations are more appropriate when increased muscle mass is the primary factor affecting creatinine levels 1
  • In a study of patients with neuromuscular disease (opposite condition to athletes), all equations overestimated kidney function, but cystatin C-based estimations performed better than creatinine-based ones 5

Limitations and Caveats

  • Cystatin C testing may be more expensive and less widely available than creatinine testing
  • Smoking can affect non-GFR determinants of cystatin C 1
  • In some clinical contexts like kidney transplantation, the added value of cystatin C for CKD detection may be limited 1

For accurate assessment of renal function in athletes, cystatin C provides a more reliable biomarker that is less influenced by the high muscle mass typical in this population, making it the preferred option for detecting early or subtle changes in kidney function.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cystatin C a marker for renal function after exercise.

International journal of sports medicine, 2009

Guideline

Chronic Kidney Disease Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.